BKD Wealth Advisors LLC reduced its position in shares of MetLife, Inc. (NYSE:MET) by 1.9% during the second quarter, Holdings Channel reports. The institutional investor owned 3,896 shares of the financial services provider’s stock after selling 76 shares during the period. BKD Wealth Advisors LLC’s holdings in MetLife were worth $214,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in MET. BlackRock Inc. boosted its position in MetLife by 3,323.3% in the first quarter. BlackRock Inc. now owns 68,475,870 shares of the financial services provider’s stock worth $3,616,895,000 after buying an additional 66,475,603 shares in the last quarter. Vanguard Group Inc. boosted its position in MetLife by 3.0% in the first quarter. Vanguard Group Inc. now owns 65,364,620 shares of the financial services provider’s stock worth $3,452,559,000 after buying an additional 1,885,246 shares during the period. State Street Corp boosted its position in MetLife by 1.4% in the first quarter. State Street Corp now owns 49,020,964 shares of the financial services provider’s stock worth $2,589,297,000 after buying an additional 680,903 shares during the period. Geode Capital Management LLC boosted its position in MetLife by 6.9% in the first quarter. Geode Capital Management LLC now owns 10,265,096 shares of the financial services provider’s stock worth $541,427,000 after buying an additional 664,918 shares during the period. Finally, Morgan Stanley boosted its position in MetLife by 5.4% in the first quarter. Morgan Stanley now owns 7,946,397 shares of the financial services provider’s stock worth $419,728,000 after buying an additional 404,104 shares during the period. Hedge funds and other institutional investors own 74.83% of the company’s stock.

Shares of MetLife, Inc. (MET) traded up 0.13% during mid-day trading on Friday, hitting $46.80. The stock had a trading volume of 2,519,567 shares. The company’s 50 day moving average price is $48.79 and its 200 day moving average price is $47.32. The stock has a market cap of $49.74 billion, a P/E ratio of 550.59 and a beta of 1.46. MetLife, Inc. has a 12-month low of $35.21 and a 12-month high of $51.77.

MetLife (NYSE:MET) last issued its earnings results on Wednesday, August 2nd. The financial services provider reported $1.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.28 by $0.02. The business had revenue of $17.39 billion for the quarter, compared to analyst estimates of $17.11 billion. MetLife had a net margin of 0.30% and a return on equity of 8.51%. The company’s revenue for the quarter was up 2.5% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.83 EPS. Equities research analysts predict that MetLife, Inc. will post $4.91 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 13th. Investors of record on Monday, August 7th will be given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 3.42%. The ex-dividend date of this dividend is Thursday, August 3rd. MetLife’s dividend payout ratio is presently 1,777.98%.

ILLEGAL ACTIVITY WARNING: “MetLife, Inc. (MET) Position Reduced by BKD Wealth Advisors LLC” was first reported by Watch List News and is owned by of Watch List News. If you are reading this news story on another site, it was copied illegally and republished in violation of United States & international copyright and trademark law. The correct version of this news story can be viewed at https://www.watchlistnews.com/metlife-inc-met-position-reduced-by-bkd-wealth-advisors-llc/1475758.html.

MET has been the topic of a number of research reports. TheStreet upgraded MetLife from a “c” rating to a “b-” rating in a research note on Monday, July 24th. Royal Bank Of Canada restated a “buy” rating and set a $62.00 price target on shares of MetLife in a research note on Wednesday, July 12th. Wells Fargo & Company restated a “buy” rating on shares of MetLife in a research note on Saturday, July 1st. Keefe, Bruyette & Woods restated a “buy” rating and set a $59.00 price target on shares of MetLife in a research note on Thursday, August 3rd. Finally, Argus decreased their price target on MetLife from $60.00 to $55.00 and set a “buy” rating on the stock in a research note on Wednesday. Two analysts have rated the stock with a sell rating, six have assigned a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of $59.17.

MetLife Company Profile

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings; Brighthouse Financial, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.